GSEA analysis of RNA-Sequencing data of positive and negative vHPC engram upregulate genes associated with neuroprotective and neurodegeneration respectively.

(a) C57BL/6J mice were bilaterally injected with a 1:1 viral cocktail of AAV9-c-Fos-tTA and AAV9-TRE-eYFP into the ventral hippocampus (vHPC). This activity-dependent labeling strategy captures sufficiently active neurons expressing the immediate-early gene, cfos. This system couples the cfos promoter to the expression of the tetracycline transactivator (tTA), which binds to the tetracycline response element (TRE) in its protein form. When doxycycline (DOX) is present, such as in the animal’s diet, this inhibits the binding of tTA to TRE, preventing eYFP labeling of active cells. (b) Experimental schematic used to label, isolate, and analyze the two groups of vHPC cells labeled by eYFP upon shock (negative) or male-to-female interaction (positive). Prior to surgery, mice were placed on a Dox diet to inhibit the labeling of active neurons. On Day 0, mice were injected with the activity-dependent viral strategy to enable labeling of active neurons during a salient experience. On Day 10 after viral expression and recovery, the mice were taken off of Dox prior to engram tagging to open the labeling window. On Day 11, mice were subjected to contextual fear conditioning (CFC) or male-to-female interaction to label negative or positive neurons, respectively. Mice were placed immediately back on Dox to close this tagging window. 24 hours later, mice were sacrificed and brains were obtained for sequencing experiments. (c) List of gene abbreviations and full names used for the gene set enrichment analysis (GSEA) of anti-inflammatory genes. (d) GSEA analysis with the enrichment score for negative vs. untagged cells and positive vs. untagged cells using the anti-inflammatory gene set. (e) List of gene abbreviations and names used for the GSEA analysis of pro-inflammatory genes. (f) GSEA analysis with the enrichment score of negative vs. untagged cells and positive vs. untagged cells using the pro-inflammatory gene set.

Experimental timeline for chronic modulation of a negative engram in TRAP2 mice.

(a) Schematic representation of tagging a negative engram in young (3 month) and old (11 month) TRAP2 mice followed by three months of chronic engram stimulation and a battery of behavioral tests. AAV9-hSyn-DIO-hM3Dq-mCherry or AVV9-hSyn-DIO-mCherry control vector was bilaterally injected into the vHPC of young and old mice. After viral expression and surgical recovery, all mice were subjected to contextual fear conditioning (CFC) in Context A and subsequent 4-hydroxytamoxifen (4-OHT) intraperitoneal (IP) injection to induce negative engram tagging. For the next three months, mice received the water-soluble Designer Receptors Exclusively Activated by Designer Drugs (DREADD) agonist deschloroclozapine dihydrochloride (DCZ) in their home cage water. After three months of stimulation wherein the young and old groups reached 6 months and 14 months of age, the mice underwent open field, y-maze, zero maze, remote recall, extinction, and generalization in a novel Context B. (b) Representative image of hSyn-DIO-hM3Dq-mCherry expression in the vHPC (red) and DAPI+ cells (blue) after 3 months of hM3Dq activation. (c) Weights of all groups were recorded over the three month stimulation protocol, once per month. (left) young 6-month old and (right) older 14-month old mice. Values are given as a mean + (SEM). Statistical analysis was performed with two-way (RM) ANOVA followed by Sidak’s post-hoc test. n=9-17 per group after outlier removal. p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001, no label = not significant

Chronic activation of an aversive engram induces behavioral changes in anxiety and working memory.

(a) Schematic of open field test; (i.) total distance traveled, (ii.) total time spent in center, (iii.) number of entries into the center, and (iv.) average speed in 6 month mCherry and hM3Dq and 14 month mCherry and hM3Dq after 3 months of stimulation. (b) Schematic of zero-maze test; (i.) total distance traveled, (ii.) total time spent in open arms, (iii.) number of entries into the open area, and (iv.) average speed. (c) Schematic of Y-maze test; (i.) total distance traveled, (ii.) percentage of spontaneous alterations, and (iii.) total number of entries into arms. Statistical measure used a two-way ANOVA with time point and group as factors. Tukey’s post-hoc tests were performed. Error bars indicate SEM. p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001, ns = not significant. n= 8-11 per group after outlier removal.

Chronic activation of the negative engram induces behavioral changes in fear memory.

(a) Schematic of contextual fear conditioning (CFC) in context A wherein 3- and 11-month-old mice received four, 1.5mA, 2 second foot shocks. Following the CFC session, the negative engram was tagged in all mice by IP injection of 4-OHT. (i.) Average percent freezing levels and total percentage freezing across the 300 second CFC session for (ii.) 6 month groups and (iii.) 14 month groups [Two-way ANOVA RM; [6 Months] Interaction: F(5,130) = 1.131, p=0.3473; Time: F(5,130) = 115.6, p<0.0001; Group: F(1,26) = 2.737, p=0.1101; Subject: F(26,130) =3.056, p<0.0001. [14 Months] Interaction: F(5,90) = 1.218, p=0.3074; Time: F(5,90) = 234.4, p<0.0001; Group: F(1,18) = 1.862, p=0.1892; Subject: F(18,90) = 2.887, p=0.0005]. (b) Schematic of remote recall performed after 3 months of negative engram stimulation. Mice were returned to context A for 5 minutes in the absence of foot shocks. (i.) Average percent freezing levels and total percentage freezing across the 300 second remote recall session for (ii.) 6 month groups and (iii.) 14 month groups [Two-way ANOVA RM; [6 Months] Interaction: F(5,85) = 15.72, p=0.0115; Time: F(5,85) = 15.72, p<0.001; Group: F(1,17) = 6.588, p=0.0200; Subject: F(17,85) = 2.458, p=0.0035. [14 Months] Interaction: F(5,130) = 0.9027, p=0.4815; Time: F(5,130) = 14.18, p<0.0001; Group: F(1,26) = 0.3967, p=0.5343; Subject: F(26,130) = 4.107, p<0.0001]. (c) Schematic of extinction wherein mice were placed in context A for 30 minutes in the absence of foot shocks. (i.) Average percent freezing levels and total percentage freezing across the 1800 second extinction session for (ii.) 6 month groups and (iii.) 14 month groups [Two-way ANOVA RM; [6 Months] Interaction: F(5,85) = 0.4133, p=0.8383; Time: F(5,85) = 1.979, p=0.0899; Group: F(1,17) = 5.494, p=0.0315; Subject: F(17,85) = 7.352, p<0.0001. [14 Months] Interaction: F(5,130) = 1,362, p=0.2570; Time: F(5,130) = 5.387, p=0.0002; Group: F(1,26) = 0.3836, p=0.5411; Subject: F(26, 130) = 11.16, p<0.0001]. (d) Schematic of the novel context B used to assess generalization. (i.) Average percent freezing levels and total percentage freezing across the 300 second generalization session for (ii.) 6 month groups and (iii.) 14 month groups [Two-way ANOVA RM; [6 months] Interaction: F(4,72) = 2.257, p=0.0713; Time: F(4,72) = 3.373, p=0.0138; Group: F(1,18) = 4.151, p=0.0566; Subject: F(18,72) = 2.537, p=0.0028. [14 Months] Interaction: F(4,100) = 2.575, p=0.0421; Time: F(4,100) = 5.717, p=0.0003; Group: F(1,25) = 6.343, p=0.0186; Subject: F(25,100) = 3.175, p<0.0001]. Statistical analysis utilized a two-way ANOVA with time point and group as factors and two-way RM ANOVA with time (seconds) and group as factors across 6- and 14-month-old mice. Tukey’s or Sidak’s post-hoc tests were performed where applicable. Error bars indicate SEM. p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001, ns = not significant. n= 8-11 per group after outlier removal.

Chronic modulation of the negative engram induces changes in the number and morphology of microglia and astrocytes.

(a-b) Representative images of Iba1+ microglia (green) in the hippocampus of (a) 6 month mCherry and hM3Dq mice and (b) 14 month mCherry and hM3Dq mice following 3 months of stimulation. (c) Number of Iba1+ cells. (d-j) Quantified morphological analysis of Iba1+ cells; (d) ramification index, (e) cell territory volume, (f) average centroid distance, (g) number of endpoints, (h) average branch length, (i) minimum branch length, and (j) maximum branch length. (k-l) Representative images of GFAP+ astrocytes (red) in the hippocampus of (k) 6 month mCherry and hM3Dq mice and (l) 14 month mCherry and hM3Dq mice following 3 months of stimulation. (m) Number of GFAP+ cells. (n-t) Quantified morphological analysis of GFAP+ cells; (n) ramification index, (o) cell territory volume, (p) average centroid distance, (q) number of endpoints, (r) average branch length, (s) minimum branch length, and (t) maximum branch length. Statistical analysis used a two-way ANOVA with time point and group as factors. Tukey’s post-hoc tests were performed. Error bars indicate SEM. p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001, ns = not significant. For cell counts, n=3 mice/group x 18 single tile ROIs each (GFAP, Iba1). For morphology, n=3 mice/group x 3 single tile ROIs each (GFAP, Iba1), each containing 20-30 glial cells.

GABA expression in the hippocampus decreases in mice that receive chronic stimulation of the negative engram.

(a) Representative images GABA+ cells (green) and DAPI+ cells (blue) in the hippocampus after 3 months of stimulation. (b) Fluorescence intensity quantification of GABA+ cells in the hippocampus after 3 months of stimulation. Statistical measure used a two-way ANOVA with time point and group as factors. Tukey’s post-hoc tests were performed. Error bars indicate SEM. p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001, ns = not significant. For fluorescence intensity measurements, n= 3 mice/group x 3-5 CA1 ROIs each (GABA).

Chronic stimulation of the negative engram does not induce neuronal death.

Representative images and quantification of NeuN+ cells in the (a-b) subiculum, (c-d) vDG, and (e-f) vCA1 of all groups (6 month mCherry and hM3Dq and 14 month mCherry and hM3Dq). Values are given as a mean + (SEM). Statistical analysis was performed with two-way ANOVA followed by Tukey’s post-hoc test. For cell counts, n=3 mice/group x 18 single tile ROIs each brain region (NeuN). No label = not significant, **p>0.001, ***p>0.0001, ****p>0.00001).

Analysis of astrocyte and microglial morphology using the MATLAB-based tool 3DMorph.

a-d) Representative 3DMorph images of GFAP+ astrocytes in (a) 6 month mCherry, (b) 6 month hM3Dq, (c) 14 month mCherry, and (d) 14 month hM3Dq mice. (e-h) Representative 3DMorph images of Iba1+ microglia in (e) 6 month mCherry, (f) 6 month hM3Dq, (g) 14 month mCherry, and (h) 14 month hM3Dq mice.